Dr. Karim Bandali is currently Associate Vice President and Chair, Cardiovascular Perfusion at The Michener Institute for Applied Health Sciences. Dr. Bandali’s research work has examined the potentially damaging effects of administering excessively high oxygen levels (hyperoxia) rarely considered when children undergo corrective heart surgery. His research has shown that exposure to hyperoxia can lead to the development of key metabolic and functional cardiovascular complications in newborns in an experimental setting. These novel findings have significant implications in the clinical use of hyperoxia which have impacted paediatric cardiac patient care. Dr. Bandali has several peer-reviewed publications and has been recognized for his scientific contributions with various prestigious awards including: The Bigelow Book prize for scientific integrity, innovation and productivity, The John Hepburn Award for excellence in cardiovascular sciences, The Richard Rowe Prize for excellence in paediatric cardiology and The President’s Award at The Michener Institute for Applied Health Sciences for curriculum innovation and strategic alliances.
In addition, Dr. Bandali also teaches several undergraduate level courses at The Michener Institute focusing on anatomy, physiology and cardiac perfusion and lectures for the Departments of Physiology and Radiation Oncology, Faculty of Medicine, University of Toronto. Dr. Bandali also leads the Student Research Program at The Michener Institute and is cross appointed as Adjunct Professor at Dalhousie University. His current interests focus the development healthcare simulation education in various medical disciplines and creation of an integrative inter-professional electronic health record.